Richard A. Meier - Jun 3, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Jun 3, 2024
Transactions value $
-$51
Form type
4
Date filed
6/4/2024, 07:28 PM
Previous filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $416K +6.6K +5.52% $63.10 126K Jun 3, 2024 Direct
transaction BMRN Common Stock Tax liability -$417K -5.45K -4.32% $76.41 121K Jun 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -6.6K -100% $0.00* 0 Jun 3, 2024 Common Stock 6.6K $63.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.